SEARCH

SEARCH BY CITATION

References

  • Allaart, C.F. & Briët, E. (1994) Familial venous thrombophilia. In: Haemostasis and Thrombosis, 3rd edn. (ed. by A.L.Bloom, C.D.Forbes, D.P.Thomas & E.G.D. Tuddenham), p1349. Churchill Livingstone, London.
  • Anderson, D., Harrison, L., Hirsh, J. (1993) Evaluation of a portable prothrombin time monitor for home use by patients who require long-term oral anticoagulant therapy. Archives of Internal Medicine, 153, 14411447.
  • Anderson, Jr, F.A., Wheeler, H.B., Goldberg, R.J., Hosmer, D.W., Patwardhan, N.A., Jovanovic, B., Forcier, A., Dalen, J.E. (1991) A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Archives of Internal Medicine, 151, 933938.
  • Anning, S.T. (1957) The historical aspects of venous thrombosis. Medicine History, 1, 2837.
  • Baillie, J. (1793) Of uncommon appearances of disease in blood vessels. Transactions of the Society for the Improvement in Medical and Chirurgical Knowledge, 1, 119.
  • Barritt, D.W. & Jordan, S.C. (1960) Anticoagulant drugs in the treatment of pulmonary embolism. Lancet, 1, 13091312.
  • Bauer, G. (1940) A venographic study of thromboembolism problems. Acta Chirurgica Scandinavica, 84, 17.
  • Bauer, G. (1942) A roentgenological and clinical study of the sequels of thrombosis. Acta Chirurgica Scandinavica, 86, 1106.
  • Bennet, R. (1891) The diseases of the Bible, Edition 2. The Religious Tract Society, London.
  • Bergqvist, D., Lindgren, B., Matzsch, T. (1996) Comparison of the cost of preventing post-operative deep vein thrombosis with either unfractionated or low molecular heparin. British Journal of Surgery, 83, 15481552.
  • Bern, M.M., Bothe, A., Bistrian, B., Champagne, C.D., Keane, M.S., Blackburn, G. (1986) Prophylaxis against central vein thrombosis. Surgery, 99, 216220.
  • Bertina, R.M., Koeleman, B.P.C., Koster, T., Rosendaal, F.R., Dirven, R.J., De Ronde, H., Van Der Velden, P.A., Reitsma, P.H. (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature, 369, 6467.
  • Best, C.H. (1959) Preparation of heparin and its use in the first clinical cases. Circulation, 19, 7983.
  • Biggs, R. & Denson, K.W.E. (1967) Standardisation of the prothrombin time for the control of anticoagulant therapy. British Medical Journal, 1, 8488.
  • Browse, N. (1972) The 125I. fibrinogen uptake test. Archives of Surgery, 104, 160163.
  • Butt, H.R., Allen, E.U., Bollman, J.L. (1941) A preparation from spoiled sweet clover C3, 31methylene-bis-(4 hydroxy-coumarin) which prolongs coagulation and prothrombin time of 120 blood: preliminary report of experiments and clinical studies. Proceedings of the staff meetings. Mayo Clinic, 16, 388395.
  • Byrne, J.J. (1955) Phlebitis: a study of 748 cases at the Boston City Hospital. New England Journal of Medicine, 253, 579586.
  • Campbell, H.A. & Link, K.P. (1941) Studies on the hemorrhagic sweet clover disease. IV. The isolation and crystallization of the hemorrhagic agent. Journal of Biological Chemistry, 138, 2133.
  • Campbell, H.A., Roberts, W.L., Smith, W.K., Link, K.P. (1940) Studies on the hemorrhagic sweet clover disease. I. The preparation of hemorrhagic concentrates. Journal of Biological Chemistry, 136, 4755.
  • Clagett, G.P., Anderson, Jr, F.A., Geerts, W., Heit, J., Knudson, M. (1998) Prevention of venous thromboembolism. Chest, 114, 531S560S.
  • Collins, R., Scrimgeour, A., Yusuf, S. (1988) Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopaedic and urologic surgery. New England Journal of Medicine, 318, 11621173.
  • Comp, P.C. & Esmon, C.T. (1984) Recurrent venous thromboembolism in patients with a partial deficiency of protein S. New England Journal of Medicine, 311, 15251528.
  • Contejean, C. (1896) Nouvelles remarques critiques au sujet du role du foie et de la masse intestinale sur l'action anticoagulante des injections intravasculaires de peptone chez le chien. CR Séances Society of Biology, 48, 753755.
  • Crafoord, C. (1939) Heparin and postoperative thrombosis. Acta Chirurgia Scandinavia, 82, 319323.
  • Dahlbäck, B., Carlsson, M., Svensson, P.J. (1993) Familial thrombophilia due to a previously unrecognised mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proceedings of the National Academy of Sciences of the United States of America, 90, 10041008.
  • De Bakey, M.E. (1954) Collective review: a critical evaluation of the problems of thromboembolism (John Calmers Da Costa oration). International Abstracts of Surgery, 98, 127.
  • de Saint Pathus (1932) Les miracles de Saint Louis. In: Classiques Français de Moyen Age, (ed. by P.B.Fay), pp. 2326. Honoré Champion, Paris.
  • Dexter, L. (1973) The chair and venous thrombosis. Transactions of the American Clinical Climatological Association, 84, 115.
  • Dexter, L. & Folch-Pi, W. (1974) Venous thrombosis. An account of the first documented case. Journal of the American Medical Association, 228, 195196.
  • Dougherty, J. & Homans, J. (1940) Venography, a clinical study. Surgery, Gynecology and Obstetrics, 71, 697710.
  • Doyon, M. (1910) Sécrétion d'antithrombine hépatique sans addition de substances étrangères au sang. CR Séances Societé Biologique, 68, 752753.
  • Duxbury, B.McD. (1982) The therapeutic control of anticoagulant therapy. British Medical Journal, 284, 592597.
  • Egeberg, O. (1965) Inherited antithrombin deficiency causing thrombophilia. Thrombosis et Diathesis Haemorrhagica, 13, 516520.
  • Faioni, E.M., Franchi, F., Asti, D., Sacchi, E., Bernardi, F., Mannucci, P.M. (1993) Resistance to activated protein C in nine thrombophilic families: interference in a protein S functional assay. Thrombosis and Haemostasis, 70, 10671071.
  • Fay, P.B. (ed.) (1932) Classiques Français de Moyen Age, pp. 2326. Honoré Champion, Paris.
  • Ferrier, J. (1810) An affectation of the lymphatic vessels hitherto misunderstood. In: Medical Histories and Reflections, III.
  • Findley, P. (1912) Puerperal thrombophlebitis. American Journal of Obstetrics, 16, 987995.
  • Francis, C.W., Marder, V.J., Evarts, C.M., Yaukoolbodi, S. (1983) Two-step warfarin therapy: prevention of post-operative venous thrombosis without excessive bleeding. Journal of the American Medical Association, 249, 374378.
  • Geerts, W.H., Heit, J.A., Clagett, P., Pineo, F., Colwell, C.W., Anderson, Jr, F.A., Wheeler, H.W. (2001) Prevention of venous thrombembolism. Chest, 119, Suppl, 132S175S .
  • Griffin, J.H., Evatt, B., Zimmerman, T., Kleiss, A., Wideman, C. (1981) Deficiency of protein C in congenital thrombotic disease. Journal of Clinical Investigation, 68, 13701373.
  • Griffin, J.H., Evatt, B., Wideman, C., Fernandez, J.A. (1993) Anticoagulant protein C pathway defective in majority of thrombophilic patients. Blood, 82, 19891993.
  • Haeger, K. (1969) Problems of acute deep vein thrombosis. The interpretation of signs and symptoms. Angiology, 20, 219223.
  • Haycraft, J.B. (1884) On. the action of a secretion obtained from the medicinal leech on the coagulation of the blood. Proceedings of the Royal Society of London, 36, 478487.
  • Hellemons, B.S.P., Langerberg, M., Lodder, J., Version Meer, F., Schouten, H.J.A., Lemmens, TH., Van Ree, J.W., Knottnerus, J.A. (1999) Primary prevention of arterial thromboembolism in non-rheumatic atrial fibrillation in primary care. British Medical Journal, 319, 958964.
  • Hewson, W. (1846) The Works of William Hewson, F.R.S. (ed. by G.Gulliver). Sydenham Society, London.
  • Hirsh, J., Dalen, J.E., Anderson, D.R., Poller, L., Bussy, H., Ansell, J., Deykin, D., Brandt, J. (1998) Oral anticoagulants. Mechanism of action; Clinical effectiveness and therapeutic range. Chest, 114, 445469S.
  • Howell, W.H. (1925) The purification of heparin and its presence in blood. American Journal of Physiology, 63, 434.
  • Howell, W.H. & Holt, E. (1918) Two new factors in coagulation, heparin and pro-antithrombin. American Journal of Physiology, 47, 328342.
  • Hull, J. (1800) An essay on phlegmasia dolens. R & W Dean, Manchester.
  • Hull, R.D., Delmore, T., Carter, I., Hirsh, J., Genton, E., Gent, M., Turpie, G., McLoughlin, D. (1982) Different intensities of oral anticoagulant treatment of proximal vein thrombosis. New England Journal of Medicine, 329, 524529.
  • Hull, R.D., Hirsh, J., Carter, C.J., Jay, R.M., Ockelford, P.A., Buller, H.R., Turpie, A.G., Powers, P., Kinch, D., Dodd, P.E. (1985) Diagnostic efficacy of impedance phlethysmography for clinically suspected deep vein thrombosis. A randomized trial. Annals of Internal Medicine, 102, 2128.
  • Hull, R.D., Raskob, G.E., Pineo, G.F. (1997) Subcutaneous low-molecular-weight heparin vs warfarin for prophylaxis of deep vein thrombosis after hip or knee implantation. An economic perspective. Archives of Internal Medicine, 157, 298303.
  • Hunter, J. (1793) Observations on the inflammation of the internal coats of veins. Transactions of the Society for the Improvement of Medical and Chirurgical Knowledge, 1, 1825.
  • Hyers, T.M., Agnelli, G., Hull, R.D., Weg, J.G., Morris, T.A., Samama, M., Tapson, V. (2001) Antithrombotic therapy for venous thromboembolic disease. Chest, 119, Suppl, 176S193S .
  • International Committee on Thrombosis Haemostasis/International Committee for Standardization in Haematology (1979) Prothrombin time standardisation: report of the expert panel on oral anticoagulant control. Thrombosis and Haemostasis, 42, 10731114.
  • Imperiale, T.F. & Speroff, T. (1994) A meta-analysis of methods to prevent venous thromboembolism following total hip replacement. Journal of the American Medical Association, 271, 17801785.
  • Johnson, E.A., Kirkwood, T.B.L., Stirling, Y. (1976) Four heparin prep: anti-Xa potentiation effect of heparin after subcutaneous injection. Thrombosis and Haemostasis, 35, 586591.
  • Johnson, T. (1678) The works of the famous chirurgeon, Ambrose Perey. Clark, London.
  • Jorpes, E. (1935) The chemistry of heparin. Biochemical Journal, 29, 18171822.
  • Kakkar, V. (1972) The diagnosis of deep vein thrombosis using the 125I fibrinogen test. Archives of Surgery, 104, 152159.
  • Kalafatis, M., Rand, M.D., Mann, K.G. (1994) The mechanism of inactivation of human factor V and human factor Va by activated protein C. Journal of Biological Chemistry, 269, 3186931880.
  • Kalafatis, M., Bertina, R.M., Rand, M.D., Mann, K.G. (1995) Characterization of the molecular defect in factor VR506Q. Journal of Biological Chemistry, 270, 40534057.DOI: 10.1074/jbc.270.8.4053
  • Kirkwood, T.B.L. (1983) Calibration of reference thromboplastin and standardisation of the prothrombin time ratio. Thrombosis and Haemostasis, 36, 230236.
  • Koster, T., Rosendaal, F.R., De Ronde, H., Briët, E., Vandenbroucke, J.P., Bertina, R.M. (1993) Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet, 342, 15031506.
  • Lensing, A.W. & Hirsh, J. (1993) 125I-fibrinogen leg scanning: reassessment of its role for the diagnosis of venous thrombosis in post-operative patients. Thrombosis and Haemostasis, 69, 27.
  • Lensing, A.W., Prandoni, P., Brandjes, D., Huisman, P.M., Vigo, M., Tomasella, G., Krekt, J., Ten Cate, J.W., Huisman, M.V., Buller, H.R. (1989) Detection of deep vein thrombosis by real-time B-mode ultrasonography. New England Journal of Medicine, 320, 342345.
  • Levine, M., Hirsh, J., Gent, M. (1994) Double blind randomized trial of a very low-dose warfarin for prevention of thromboembolism in stage IV breast cancer. Lancet, 343, 886889.
  • Levret, A. (1766) L'art des acouchements, 3rd edn. Didot, Paris.
  • Link, K.P. (1959) The discovery of dicumarol and its sequels. Circulation, 19, 97107.
  • Lockwood, D.P. (1951) Ugo Benzi. medieval philosopher and physician, pp. 13761439. University Press, Chicago.
  • Loeliger, E.A., Poller, L., Samama, M., Verstraete, M. (1984) Questions and answers on prothrombin time standardisation in oral anticoagulant control. Thrombosis and Haemostasis, 54, 514518.
  • McLean, J. (1916) The thromboplastic action of cephalin. American Journal of Physiology, 41, 250257.
  • Miale, J.B. & La Fond, D.J. (1967) Prothrombin time standardisation – 1963 Prothrombin time test survey. College of American Pathologist Standard Subcommittee on Coagulation. American Journal of Clinical Pathology, 47, 4046.
  • Mohr, D.N., Silverstein, M.D., Murtaugh, P.A., Imperiale, T.F., Speroff, T. (1993) Prophylactic agents for venous thrombosis in elective hip surgery. Meta-analysis of studies using venographic assessment. Archives of Internal Medicine, 153, 22212228.
  • Nordstrom, M., Lindblad, B., Bergqvist, D., Kjellstrom, T. (1992) A prospective study of the incidence of deep-vein thrombosis within a defined urban population. Journal of Internal Medicine, 232, 155160.
  • Ockelford, P.A., Patterson, J., John, A.S. (1989) A double blind randomized placebo control trial of thromboprophylaxis in major elective surgery using once daily injections of a low-molecular weight heparin (Fragmin). Thrombosis and Haemostasis, 62, 10461049.
  • Owen, C.A. & Bowie, E.J.W. (1996) The history of the development of oral anticoagulant drugs. In: Oral Anticoagulants (ed. by L.Poller & J.Hirsh), pp. 18. Arnold, London.
  • Poller, L. (1964) The standardisation of oral anticoagulant treatment – the Manchester Regional Thromboplastin Scheme. British Medical Journal, ii, 565566.
  • Poller, L., McKernan, A., Thomson, J.M., Elstein, M., Hirsch, P.J., Jones, J.B. (1987) Fixed minidose warfarin: a new approach to prophylaxis against venous thrombosis after major surgery. British Medical Journal, 295, 13091312.
  • Poller, L., Van Den Besselaar, A.M.H.P., Jespersen, J., Tripodi, A., Houghton, D. for the European Concerted Action on Anticoagulation (ECAA) (1998a) A comparison of artificially depleted, lyophilized coumarin and fresh coumarin plasmas in thromboplastin calibration. British Journal of Haematology, 101, 462467.DOI: 10.1046/j.1365-2141.1998.00728.x
  • Poller, L., Van Den Besselaar, A.M.H.P., Jespersen, J., Tripodi, A., Houghton, D. for the European Concerted Action on Anticoagulation (ECAA) (1998b) Field studies of coagulometer effects on the ISI of ECAA thromboplastins. Thrombosis and Haemostasis, 80, 615623.
  • Poller, L., Shiach, C.R., MacCallum, P.K., Johansen, A.M., Münster, A.M., Magalhães, A., Jespersen, J. for the European Concerted Action on Anticoagulation (1998c) Multicentre randomized study of computerised anticoagulant dosage. Lancet, 352, 15051509.DOI: 10.1016/s0140-6736(98)04147-6
  • Poort, S.R., Rosendaal, F.R., Reitsma, P.M., Bertina, R.M. (1996) A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood, 88, 36983703.
  • Popkin, R.J. (1962) The post-thrombophlebitic syndrome. Charles C Thomas, Springfield.
  • Prandoni, P. & Mannucci, P.M. (1999) Deep vein thrombosis of the lower limbs: diagnosis and management. Baillieres Best Practice in Clinical Hematology, 12, 533554.
  • Roderick, L.M. (1929) The pathology of sweet clover disease in cattle. Journal of the American Veterinary Medical Association, 74, 314315.
  • Roderiguez Castro, A. (1604) De universa mulierum morborum medicina. Froberiana, Hamburg.
  • Rokitansky, C. (1852) Pathological anatomy, IV, 336. Sydenham Society, London.
  • Rosendaal, F.R., Cannengieter, S.C., Van Der Meer, F.J.M., Briët, E. (1993 )A method to determine the optimal intensity of oral anticoagulant therapy. Thrombosis and Haemostasis, 69, 236239.
  • Samama, M., Bernard, P., Bonnardot, J.P. (1988) Low molecular weight heparin compared with unfractionated heparin in prevention of postoperative thrombosis. British Journal of Surgery, 75, 128131.
  • Schmidt-Mulheim, A. (1880) Beiträge zur Kenntnis des Peptons und seiner physiologischen Bedeutung. Arch für Anatomie und Physiologie. Physiologische Abteilung, 33, 56.
  • Schofield, F.W. (1924) Damaged sweet clover. The cause of a new disease in cattle simulating hemorrhagic septicemia and blackleg. Journal of the American Veterinary Medical Association, 64, 553575.
  • Schwartz, H.P., Fischer, M., Hopmeier, P., Batard, M., Griffin, J. (1984) Plasma protein S deficiency in familial thrombotic disease. Blood, 64, 12971300.
  • Sevitt, S. & Gallagher, N.G. (1959) Prevention of venous thrombosis and pulmonary embolism in injured patients; a trial of anticoagulant prophylaxis with phenindione in middle-aged and elderly patients with fractured necks of femur. Lancet, ii, 981989.
  • Sproul, E.E. (1938) Carcinoma and venous thrombosis: the frequency of associations of carcinoma in the body or tail of the pancreas with multiple venous thrombosis. American Journal of Cancer, 34, 566585.
  • Starr, A., Frank, H.A., Fine, J. (1942) The venographic diagnosis of thrombophlebitis of the lower extremities. Journal of the American Medical Association, 118, 11921195.
  • Taberner, D.A., Poller, L., Burslem, R.W., Jones, J.B. (1978) Oral anticoagulants controlled by the British comparative thromboplastin versus low-dose heparin in prophylaxis of deep vein thrombosis. British Medical Journal, 1, 272274.
  • Trousseau, A. (1866) Phlegmasia alba dolens. Clinique Medical de l'Hotel-Dieu, 3, 654712.
  • Virchow, R. (1860) Cellular pathology. Churchill, London.
  • World Health Organization (1983) Expert Committee of Biological Standardisation 33rd Report. WHO Technical Series, 700, 1930.
  • Wiseman, R. (1676). Severall Chirurgicall Treatises, p. 64. Norton and Macock, London.
  • Wright, I.S., Marple, C.D., Beck, D.F. (1954) Myocardial infarction: Its clinical significance and treatment with anticoagulants. A study of 1031 cases. Grune Stratton, New York.